Monday, August 4, 2025

Latest

Cronos Group Posts Revenues of US$7.3 Million For Q4 2019, Loss of US$63.8 Million

Cronos Group (TSX: CRON) (NASDAQ: CRON) has finally reported its fourth quarter and full fiscal year 2019 financial results after delaying earnings twice previously. Notably, the company has switched from reporting in Canadian Dollars to that of US Dollars. For the fourth quarter, the company reported revenues of US$7.3 million (C$10.3 million).

Revenues for the fourth quarter are a decrease from previously reported third quarter net revenues of C$12.7 million, however are an increase from the revised figure for the third quarter of C$7.6 million. Sales consisted of US$2.69 million (C$3.81 million) from the US, while US$4.61 million (C$6.52 million) was from the firms Canadian cannabis operations, with Canadian sales believed to be demonstrating a quarter over quarter decrease of US$0.73 million (C$1.03 million). The company reported a gross loss of US$20.3 million for the quarter, or a negative gross profit margin of 279%.

For the full fiscal year of 2019, Cronos reported net revenues of US$23.7 million (C$33.6 million), with a gross loss of US$17.8 million or a negative gross profit margin of 75%.

The firms cash position during the quarter increased to US$1.19 billion (C$1.69 billion) from US$1.04 billion (C$1.47 billion), while short term investments decreased to US$306.3 million (C$433.5 million) from that of US$365.3 million (C$517.0 million).

Notable items include an inventory writedown of US$24.0 million (C$33.9 million), which was largely comprised on the writedown of the value of cannabis plants and cannabis oil. Also notable is that Cronos posted an operating loss of US$63.8 million (C$90.3 million) during the fourth quarter, largely driven by inventory writedowns and increased general and administrative expenses. The firm lost US$121.4 million (C$171.9 million) for the full fiscal year.

Full financial results have yet to be filed by Cronos Group.

Cronos Group last traded at $6.34 on the Nasdaq.


Information for this analysis was found via Sedar and Cronos Group. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

San Dimas: First Majestic Silver’s Sleeper Asset

New Gold Q2 Earnings: Record Free Cash Flow

STLLR Gold: The Tower Gold PEA

Recommended

Tsunami Warnings Spread As Largest Quake Since 2011 Hits Russia

Northern Superior Intersects 1.75 g/t Gold Over 65.0 Metres At Philibert

Related News

Raymond James: Cronos Financials A “Relative Non-Event”

On February 26th, Cronos Group (TSX: CRON) (NASDAQ: CRON) reported fourth quarter and full year...

Sunday, February 28, 2021, 01:40:00 PM

Cronos Group Posts Revenues Of $12.6 Million, Net Loss Of $161.6 Million

Cronos Group (TSX: CRON) (NASDAQ: CRON) this morning reported its first quarter financial results, leaving...

Friday, May 7, 2021, 08:18:02 AM

Medipharm Labs and Cronos Group Sign Second Manufacturing Agreement

Medipharm Labs (TSX: LABS) and Cronos Group (TSX: CRON) (NASDAQ: CRON) have entered into their...

Thursday, September 19, 2019, 09:23:17 AM

Cronos Group Posts Fourth Quarter Revenues Of $17.0 Million, Net Loss Of $111.7 Million

Cronos Group (TSX: CRON) (NASDAQ: CRON) this morning reported its fourth quarter and full year...

Friday, February 26, 2021, 08:39:10 AM

Cronos: Raymond James Remains Bullish Despite Revenue Miss

Cronos Group (TSX: CRON) (NASDAQ: CRON) reported its first-quarter financial results on Friday, May 7th....

Tuesday, May 11, 2021, 05:47:00 PM